Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Skin Repair Research Peptides: Mechanism Comparison

KLOW MC1R activation → NF-κB inhibition → cytokine suppression Inflammation resolution, fibrosis prevention, scar quality studies 4–6 hours (topical/SC) Targets inflammatory phase without suppressing proliferation; copper-independent Cleanest mechanistic isola

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • KLOW
  • MC1R activation → NF-κB inhibition → cytokine suppression
  • Inflammation resolution, fibrosis prevention, scar quality studies
  • 4–6 hours (topical/SC)
  • Targets inflammatory phase without suppressing proliferation; copper-independent
  • Cleanest mechanistic isolation for cytokine-focused protocols
  • GHK-CU
  • MMP upregulation, copper-dependent collagen synthesis modulation
  • Matrix remodeling, photoaging models, general wound closure
  • 8–12 hours
  • Dual metalloproteinase and growth factor activity; requires copper ion coordination
  • Broad-spectrum regenerative tool but introduces oxidative stress variables
  • TB-500 (Thymosin Beta-4)
  • Actin sequestration, cell migration, angiogenesis promotion
  • Acute wound closure, re-epithelialization, vascular density studies
  • 12–18 hours
  • Strongest migration and angiogenesis signal among listed peptides
  • First choice for diabetic ulcer or ischemic wound models
  • KPV
  • MC1R/MC3R/MC4R activation, systemic anti-inflammatory signaling
  • Inflammatory skin conditions, systemic immune modulation research
  • 6–9 hours
  • Broader receptor profile than KLOW; systemic effects beyond dermal tissue
  • Better for full-body inflammation models; less dermal specificity
  • BPC-157
  • VEGF pathway, nitric oxide modulation, angiogenesis
  • Tendon/ligament repair, vascular-focused wound healing
  • 24+ hours
  • Strongest angiogenic signal; minimal direct anti-inflammatory activity
  • Use when perfusion or vascular density is the dependent variable